| Northwest Gastroenterology Professional Llc | |
|
3111 Woburn St Ste 201 Bellingham WA 98226-6610 | |
| (360) 734-1420 | |
| (360) 733-1659 |
| Full Name | Northwest Gastroenterology Professional Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 3111 Woburn St Ste 201, Bellingham, Washington |
| Authorized Official Name and Position | Cheryl L Persse (CHIEF ADMINISTRATIVE OFFICER) |
| Authorized Official Contact | 3605435054 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Northwest Gastroenterology Professional Llc 3111 Woburn St Ste 201 Bellingham WA 98226-6610 Ph: (360) 734-1420 | Northwest Gastroenterology Professional Llc 3111 Woburn St Ste 201 Bellingham WA 98226-6610 Ph: (360) 734-1420 |
| NPI Number | 1033278411 |
|---|---|
| Provider Enumeration Date | 12/08/2006 |
| Last Update Date | 05/24/2023 |
| Medicare PECOS PAC ID | 9335052265 |
|---|---|
| Medicare Enrollment ID | O20031107000129 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033278411 | NPI | - | NPPES |
| 7048408 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | (* (Not Available)) | Primary |
| Provider Name | Kelly D Mccullough |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1841256260 PECOS PAC ID: 0840230553 Enrollment ID: I20050511000821 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
| Provider Name | Todd N Witte |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1093847949 PECOS PAC ID: 1759487036 Enrollment ID: I20070502000605 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
| Provider Name | Benjamin Siemanowski |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1548301120 PECOS PAC ID: 0244337285 Enrollment ID: I20070525000302 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
| Provider Name | Kristin M Page |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992966436 PECOS PAC ID: 3779658570 Enrollment ID: I20080813000426 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
| Provider Name | Jody L Bauer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003904061 PECOS PAC ID: 7012033491 Enrollment ID: I20100922000899 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
| Provider Name | Alan G.y. Chang |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1255398285 PECOS PAC ID: 7719963230 Enrollment ID: I20100923001467 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
| Provider Name | Christoph Reitz |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1639135007 PECOS PAC ID: 8325024771 Enrollment ID: I20101117000954 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
| Provider Name | Gregory W Munson |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1982610937 PECOS PAC ID: 8224100953 Enrollment ID: I20110810000031 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
| Provider Name | Donald E Gullickson |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1275775058 PECOS PAC ID: 2062676687 Enrollment ID: I20161228001519 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
| Provider Name | Kristina Ross |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1568738458 PECOS PAC ID: 9638304769 Enrollment ID: I20190710001924 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
| Provider Name | Alison Elizabeth Freeman |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1235454091 PECOS PAC ID: 4981904018 Enrollment ID: I20220412002356 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
| Provider Name | Jash Nettar Bansal |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1225484207 PECOS PAC ID: 3971898255 Enrollment ID: I20220816000940 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
| Provider Name | Rinad Tabbalat |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1609392059 PECOS PAC ID: 6103199666 Enrollment ID: I20230705000841 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
| Provider Name | Dylan Alexander Stanfield |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1306371125 PECOS PAC ID: 7911277116 Enrollment ID: I20230809003732 |
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
News Archive
Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.
A pay-for-performance program in electronic-health-records-(EHR)-enabled small practices led to modest improvements in cardiovascular care processes and outcomes, according to a study in the September 11 issue of JAMA.
Whereas formerly often only the symptoms of age were treated in cosmetic medicine, autologous stem cell-assisted regenerative therapies take a more comprehensive approach: the abundant stem cells in fat tissue are extracted and introduced in the body. The autologous stem cells then exert their regenerative power in the body where needed. Organs and tissues are regenerated and rejuvenated; even degenerative and chronic diseases are treatable.
› Verified 6 days ago
Harbor Integrative Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2114 James St, Bellingham, WA 98225 Phone: 360-527-5232 | |
Steadfast Wellness Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 424 W Bakerview Rd Ste 105-2186, Bellingham, WA 98226 Phone: 360-553-0135 | |
Sea Mar Chc Bellingham Sud Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3350 Airport Dr, Bellingham, WA 98226 Phone: 360-734-5458 Fax: 360-734-5298 | |
Foster Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1815 C St, K37, Bellingham, WA 98225 Phone: 360-671-6350 Fax: 360-671-9611 | |
Walk In Health Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2940 Squalicum Pkwy, Suite 205, Bellingham, WA 98225 Phone: 360-734-2330 Fax: 360-733-3886 | |
Sea-mar Community Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4455 Cordata Pkwy, Bellingham, WA 98226 Phone: 360-671-3225 Fax: 360-671-0000 |